The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB 1 receptor antagonism ? or inverse agonism ? as potential obesity treatment and other therapeutic use

Saved in:
Bibliographic Details
Published inJournal of clinical pharmacy and therapeutics Vol. 32; no. 3; pp. 209 - 231
Main Authors Xie, S., Furjanic, M. A., Ferrara, J. J., McAndrew, N. R., Ardino, E. L., Ngondara, A., Bernstein, Y., Thomas, K. J., Kim, E., Walker, J. M., Nagar, S., Ward, S. J., Raffa, R. B.
Format Journal Article
LanguageEnglish
Published 01.06.2007
Online AccessGet full text

Cover

More Information
ISSN:0269-4727
1365-2710
DOI:10.1111/j.1365-2710.2007.00817.x